Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BMY - Bolt Biotherapeutics Aims For $150 Million U.S. IPO

BMY - Bolt Biotherapeutics Aims For $150 Million U.S. IPO

Bristol-Myers Squibb Company
  • Bolt Biotherapeutics has filed proposed terms for a $150 million IPO.
  • The firm is developing antibody conjugate treatments for various cancers.
  • BOLT has produced early efficacy results for its lead program and has an impressive investor syndicate, so the IPO is worth consideration.

For further details see:

Bolt Biotherapeutics Aims For $150 Million U.S. IPO
Stock Information
Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com
Menu
BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...